Glow (BPC-157 + TB-500 + GHK-Cu)

Glow, also called the Glow Blend, is a research blend combining three peptides: BPC-157, TB-500, and GHK-Cu. It pairs two peptides associated with tissue repair research with GHK-Cu, the copper peptide most studied for skin and connective-tissue renewal. It is categorized across longevity and foundation research areas, reflecting a mixed focus on repair and structural renewal. It is supplied for laboratory research use only.

The blend spans repair signaling and structural remodeling. BPC-157 has been studied in relation to angiogenic and epithelial pathways, TB-500 is associated with actin regulation, and GHK-Cu is linked to copper-dependent collagen biology. The rationale is that compounds studied for tissue recovery are combined with one studied specifically for dermal and structural protein synthesis. These mechanisms come from research on the individual components rather than on the combined blend.

BPC-157 has been reviewed for wound healing and musculoskeletal soft tissue healing, largely in animal models, with a small report on intra-articular use for knee pain. GHK-Cu has been studied for regenerative and protective actions, including gene expression data and its potential as an anti-aging peptide. TB-500 research centers on actin-related tissue repair. The three-peptide combination has not been evaluated as a unit in published studies.

Human safety data for the Glow combination are limited, and adverse events are not summarized for the blend in published studies. Recent reviews of BPC-157 have framed its use as a question of regeneration versus risk, noting that clinical evidence remains thin. Long-term human safety for the individual components has not been established, so safety conclusions drawn from animal and cell studies should be treated cautiously.

Research protocols have used 1.75 to 3.5 mg per administration, once daily in the morning, by the subcutaneous route. These protocols describe a loading phase followed by a lower-frequency maintenance phase, run in 8-week blocks with 4 weeks off. These figures describe research protocols only and are not recommendations. Each CoreX order ships with a protocol guide for laboratory reference.